A] Financial Results for Q1 FY27

The Board approved the unaudited financial results for the quarter ended June 30, 2026 (Q1 FY27), in accordance with Regulation 33 of the SEBI Listing Regulations and Ind AS 34.

Key Financial Figures (Quarter ended June 30, 2026, in ₹ Crores, except per share data):

  • Revenue from operations: ₹1,813.68
  • Other income: ₹75.37
  • Total Income: ₹1,889.05
  • Total Expenses: ₹1,316.84
  • Cost of materials consumed: ₹150.63
  • Purchases of stock-in-trade: ₹812.06
  • Changes in inventories: (₹31.10)
  • Employee benefits expense: ₹175.24
  • Finance costs: ₹5.91
  • Depreciation and amortisation: ₹19.75
  • Other expenses: ₹184.35
  • Profit before tax: ₹572.21
  • Total Tax Expenses: ₹143.69
  • Current tax expense: ₹146.87
  • Tax adjustment for earlier years: ₹0.00 (Nil)
  • Deferred tax credit: (₹3.18)
  • Profit for the period: ₹428.52
  • Other Comprehensive Income (net of tax): ₹0.04
  • Total Comprehensive Income: ₹428.56
  • Paid-up Equity Share Capital: ₹21.25 Crores (Face Value ₹10 per share)
  • Earnings per equity share (Basic/Diluted): ₹201.66

Comparative Figures:

  • Revenue from operations (Q1 FY26): ₹1,738.35 Crores
  • Profit for the period (Q1 FY26): ₹365.86 Crores
  • EPS (Q1 FY26): ₹172.17

Notes on Financials:

  • The results were reviewed by the Audit Committee and approved by the Board.
  • The statutory auditors, Walker Chandiok & Co LLP, issued an unqualified Limited Review Report.
  • The figures for the previous quarter (March 31, 2026) are balancing figures between the audited annual results and the previously published year-to-date figures.
  • The company has a single reportable segment: 'Pharmaceuticals'.
  • Previous period figures have been regrouped/reclassified where necessary.

B] Appointment of Chairman of the Board

Resignation: Mr. Munir Shaikh (DIN: 00096273), a Non-executive Director, stepped down as Chairman effective close of business hours on August 12, 2026.

Appointment: Pursuant to the company's Articles of Association and based on the recommendation of the Nomination and Remuneration Committee, Mr. Sudarshan Jain (DIN: 00927487), an Independent Director, was appointed as the new Chairman of the Board effective August 13, 2026.

Signatories and Attestation

The disclosure was signed by Sangeeta Shetty, Company Secretary (Membership No.: ACS 18865). The financial results were signed by Kartik Rajendran, Managing Director (DIN: 09527717). The Limited Review Report was signed by Ashish Gupta, Partner of Walker Chandiok & Co LLP (Firm Registration No: 001076N/N500013; Membership No. 504662; UDIN: 26504662UWISAU5097), dated August 12, 2026.